LUCAT1 and neoplasm: Cell lines from osteosarcomas that display resistance to methotrexate, an extremely potent chemotherapeutic agent used in this type of neoplasia, have been demonstrated to contain amplified lung cancer-associated transcript 1 (LUCAT1) expression (178).